ORIC-944

· ORIC Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ORIC-944, covering 2025-08-11 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: Study of ORIC-944 in Patients With Metastatic Prostate Cancer [Phase 1]